Increasing prevalence of anxiety and depression, coupled with innovation in pharmaceutical treatments and growing demand for mental health solutions, fuels growth in the anxiety disorders and ...

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

In recent years, cannabidiol (CBD) has become a popular remedy for a variety of issues. It’s nonintoxicating, and research shows promise in helping to ease pain — which, if coping with ...

James has been writing about technology for years but has loved it since the early 90s. While his main areas of expertise are maker tools -- 3D printers, vinyl cutters, paper printers, and laser ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Social media use in teenagers is strongly correlated to higher anxiety and depression, according to new ...

Modern life has eased daily routines but introduced anxiety, exacerbated by stress, constant connectivity, and lifestyle habits. Post Covid-19, 88% of Indians report anxiety. Recognizing anxiety ...

Mindfulness-based stress reduction (MBSR) was found to be as effective as the antidepressant escitalopram in reducing agoraphobia, panic disorder, generalized anxiety disorder, and social anxiety ...